Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

0.885
Delayed Data
As of Oct 18
 -0.045 / -4.84%
Today’s Change
0.80
Today|||52-Week Range
5.77
-72.25%
Year-to-Date
No recent news for DelMar Pharmaceuticals Inc.

Today’s Trading

Previous close0.93
Today’s open0.91
Day’s range0.88 - 0.93
Volume557,753
Average volume (3 months)741,062
Market cap$20.0M
Dividend yield--
Data as of 10/18/2017

Growth & Valuation

Earnings growth (last year)+8.64%
Earnings growth (this year)+82.43%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book88.15

Competitors

 Today’s
change
Today’s
% change
IMRNImmuron Ltd+0.46+9.15%
ANTHAnthera Pharmaceutic...+0.10+6.49%
EYEGEyeGate Pharmaceutic...+0.02+1.83%
ONTXOnconova Therapeutic...+0.02+0.84%
Data as of 10/18/2017

Financials

Next reporting dateNovember 21, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$8.1M
Net profit margin--

Profile

Sector
Distribution Services
Industry
Wholesale Distributors
President &
Chief Executive Officer
Jeffrey A. Bacha
Chief Financial &
Principal Accounting Officer
Scott Praill
Corporate headquarters
Vancouver, British Columbia

Forecasts